ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 147 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,225 | -97.9% | 1,075 | -97.4% | 0.00% | – |
| Q2 2023 | $156,347 | +1548.5% | 41,804 | +1376.7% | 0.00% | – |
| Q1 2023 | $9,484 | -75.9% | 2,831 | -65.4% | 0.00% | – |
| Q4 2022 | $39,384 | -64.2% | 8,188 | -57.8% | 0.00% | – |
| Q3 2022 | $110,000 | -19.1% | 19,407 | +1.3% | 0.00% | – |
| Q2 2022 | $136,000 | -13.4% | 19,161 | -11.6% | 0.00% | – |
| Q1 2022 | $157,000 | -57.1% | 21,687 | -47.1% | 0.00% | – |
| Q4 2021 | $366,000 | +36.6% | 40,967 | +435.6% | 0.00% | – |
| Q3 2021 | $268,000 | +262.2% | 7,649 | +122.4% | 0.00% | – |
| Q2 2021 | $74,000 | -76.1% | 3,440 | -31.2% | 0.00% | – |
| Q1 2021 | $309,000 | +168.7% | 4,997 | +81.9% | 0.00% | – |
| Q4 2020 | $115,000 | – | 2,747 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |